← FDA Drug Approvals (Drugs@FDA)
BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HIKMA · Approved 2023-01-17
Drug application
- FDA Application #
ANDA077838- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE
- Generic name
- Betamethasone Acetate
- Active ingredients
- BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- HIKMA
- First approval
- 2023-01-17
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown